Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

The lowball price of the securities spooked marijuana investors.

Tilray Stock Dives 32% on New Stock/Warrant Issue

Tilray (TLRY) news for Friday concerning a new registered offering from the marijuana company has TLRY stock taking a beating.
The post Tilray News: Why TLRY Stock Is Tanking 33% Today appeared first on InvestorPlace.

Tilray News: Why TLRY Stock Is Tanking 33% Today

Tilray Inc. (NASDAQ: TLRY) announced Friday that it has priced a $90.4-million equity offering.

Tilray Shares Plunge On The Heels Of $90.4M Equity Offering

Most companies that need to raise capital or that want to build up a cushion should do so when times are good or when their shares are doing well.

Tilray’s Ghastly Timing for a Capital Raise

Tilray Inc. TLRY, +4.10% said Friday that it had priced a $90.4 million stock offering at $4.76 a share.

Tilray stock slides 27% after pricing $90 million equity offering

Aurora Cannabis

MedMen Enterprises Inc.

Be prepared to lose money if you're buying these marijuana stocks.

3 Cannabis Stocks I Wouldn't Buy With Free Money

CannTrust Holdings

HEXO Corp

OrganiGram Holdings Inc.

The industry could look a whole lot different by the end of this year.

3 Things to Watch For in the Canadian Cannabis Market in 2020

Canopy Growth

Cronos Group

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

GW Pharmaceuticals

Innovative Industrial Properties

Cannabis stock valuations have gone up in smoke.

There Were Once 20 Pot Stocks With a $1 Billion Valuation or Higher. Only 8 Remain.

Pot stocks are getting caught up in the overall market sell-off.

Why Top Marijuana Stocks Are Sinking Today

SeaWorld Entertainment

Shake Shack

A theme park operator that was hitting new highs just 13 trading days earlier, a former cannabis darling, and a "better burger" cult fave all hit fresh 52-week lows this past week.

3 Surprising Stocks Hitting New Lows Last Week

It is time to sift through the clouds of smoke and take a fresh look at these three cannabis stock picks that are ready to run higher.

3 Cannabis Stocks That Are Ready to Run

Amyris

Arena Pharmaceuticals

Psychedelic Medicine Stocks Capture The Attention Of Investors

Tesla

SPDR Gold Trust

Tesla, Tilray, Cronos Group and the gold ETF (GLD) were our top stock trades for Wednesday. That said, here's a look at the charts.

4 Top Stock Trades for Wednesday: TSLA, TLRY, GLD, CRON

Tilray Inc (NASDAQ: TLRY) reported a fourth-quarter adjusted EBITDA loss of $35 million, highter than the $20.4-million loss the Street was expecting and Tilray's $13.3-million loss in the same period last year.

Tilray Shares Fall After Q4 Print, Analyst Questions Positive EBITDA Projection

Investors weren't happy with the Canadian cannabis producer's Q4 update.

Why Tilray Shares Are Falling Today

It makes sense to keep an eye on Aurora Cannabis and two others this month.

3 Top Marijuana Stocks to Watch in March

Canada-based pot firm Tilray reported a bigger quarterly loss on Monday, hurt by an impairment charge related to its assets and higher costs, as oversupply and other challenges weigh on the Canadian marijuana market.

Cannabis producer Tilray reports bigger quarterly loss on impairment charges

The Canadian cannabis producer's Q4 results weren't great. But there were a few bright spots.

The 3 Most Important Things to Know About Tilray's Q4 Update

Tilray, Inc. (TLRY) CEO Brendan Kennedy on Q4 2019 Results - Earnings Call Transcript

Tilray and other marijuana stocks dropped late Monday after quarterly results missed expectations, amid struggles in its U.S. business.

Pot Stock Misses Q4 Views Amid Competition Vs. Illicit Market, CBD Woes

The company enjoyed tremendous momentum in Q4 compared with the prior-year period. But it continues to spend a lot more than it makes.

Tilray Posts Huge Revenue Growth -- and a Huge Loss -- in Q4

Tilray (TLRY) earnings for the Canadia cannabis company's fourth quarter of 2019 have TLRY stock taking a beating after-hours Monday.
The post Tilray Earnings: TLRY Stock Takes 9% Dive on Q4 Miss appeared first on InvestorPlace.

Tilray Earnings: TLRY Stock Takes 9% Dive on Q4 Miss

Tilray, Inc. (NASDAQ: TLRY) reported fourth-quarter losses at $2.14 per share, which does not compare to the 35-cent loss estimate.

Tilray Falls On Big Q4 Earnings, Sales Miss

Tilray Inc. (NASDAQ: TLRY) released fourth-quarter financial results after the closing bell on Monday.

Tilray’s Q4 Up in Smoke

Tilray Inc. (NASDAQ: TLRY) is scheduled to release its most recent quarterly results after the markets close on Monday.

News for Tilray Brands Stock (TLRY)